EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Characteristics and Outcomes of Second Primary Multiple Myeloma in Adult Cancer Survivors: A Population‐Based Cohort Study

Nannan Li iD, Jiangping Zeng, Zhixiang Jia, Jinyuan Lu, Yuting Ma, Guangming Wang, Aibin Liang, Wenjun Zhang

Cancer Medicine · 2025

DOI: 10.1002/cam4.71393 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Cancer Medicine, 2025. Verfasst von Nannan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Multiple Myeloma, Neoplasms, Second Primary, Cancer Survivors. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Shanghai Municipal Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to investigate characteristics and outcomes of second primary multiple myeloma (2‐MM) stratified by prior primary malignancies (PPMs), and further explore the effect of PPM treatment modalities on multiple myeloma (MM) prognosis in the United States (US) population.

Methods

The retrospective study was analyzed based on MM patients in the Surveillance, Epidemiology, and End Results (SEER) database (2000–2021). Patients with 2‐MM, defined as MM diagnosed ≥ 6 months after a PPM, were stratified into 25 subgroups based on PPM categories. Univariable and multivariable competing risk regression models were constructed to estimate MM‐specific mortality. The Kaplan–Meier method and a multivariable Cox regression model were conducted to analyze all‐cause mortality.

Result

We identified 74,932 patients with first primary multiple myeloma (1‐MM) and 6465 patients with 2‐MM. Compared to the 1‐MM cohort, the 2‐MM cohort exhibited a higher proportion of males, older age at diagnosis, and greater representation of the White race. The multivariable analysis demonstrated a reduced risk of MM‐specific mortality in 2‐MM against 1‐MM. PPMs of soft tissue (including heart), melanoma of the skin, corpus uteri, prostate, kidney and renal pelvis, and lymphoma, showed protective effects on MM‐specific mortality in 2‐MM. Notably, many PPMs that developed into 2‐MM exhibited elevated all‐cause mortality risks in multivariable analysis. Additionally, chemotherapy for prior lymphoma was associated with an increased all‐cause mortality risk in 2‐MM patients, whereas, radiotherapy for prior breast cancer and surgery for prior prostate cancer were linked to a decreased risk.

Conclusion

Compared to 1‐MM, 2‐MM exhibited distinct characteristics and survival outcomes in adults, which were associated with PPM types and their treatment modalities. These findings provide critical insights for risk stratification and survivorship care in US adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaNeoplasms, Second PrimaryCancer SurvivorsHumansMaleFemaleMiddle AgedAgedRetrospective StudiesSEER ProgramUnited StatesAdultPrognosisAged, 80 and overRisk Factors

Stichwörter der Autor:innen

MM‐specific mortalitySEERall‐cause mortalityfirst primary multiple myelomaprior primary malignancysecond primary multiple myelomatreatment modalities

Autor:innen und Institutionen

  • Tongji University School of Medicine, Shanghai, China.
  • Department of Hematology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Endocrinology and Metabolism, Suzhou Dushu Lake Hospital, The Fourth Affiliated Hospital of Soochow University, Medical Center of Soochow University, Suzhou, Jiangsu, China.
  • Department of Hematology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
  • Stem Cell Research Center, East Hospital, Tongji University School of Medicine, Shanghai, China.

ORCID-Profile: Nannan Li

Förderung

  • the National Natural Science Foundation of China
  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Li, N., Zeng, J., Jia, Z., Lu, J., Ma, Y., Wang, G., Liang, A., & Zhang, W. (2025). Characteristics and Outcomes of Second Primary Multiple Myeloma in Adult Cancer Survivors: A Population‐Based Cohort Study. Cancer Medicine. https://doi.org/10.1002/cam4.71393

Vancouver

Li N, Zeng J, Jia Z, Lu J, Ma Y, Wang G, et al. Characteristics and Outcomes of Second Primary Multiple Myeloma in Adult Cancer Survivors: A Population‐Based Cohort Study. Cancer Medicine. 2025. doi:10.1002/cam4.71393

BibTeX
@article{Li2025,
  author = {Li, Nannan and Zeng, Jiangping and Jia, Zhixiang and Lu, Jinyuan and Ma, Yuting and Wang, Guangming and Liang, Aibin and Zhang, Wenjun},
  title = {Characteristics and Outcomes of Second Primary Multiple Myeloma in Adult Cancer Survivors: A Population‐Based Cohort Study},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71393}
}
Kostenlos starten →